IRCT20220516054868N2
Recruiting
Phase 4
Evaluation and comparing the possible side effects of rivaroxaban with warfarin in patients with pulmonary valve replacement or Fontan surgery.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 75
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Obtaining informed consent (patient or parents)
- •Age 5\-18 years old
- •Performed pulmonary valve replacement or Fontan surgery
Exclusion Criteria
- •Intolerance or sensitivity to warfarin
- •Intolerance or sensitivity to rivaroxaban
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparison of the efficacy and possible side effects of high and standard doses of rifampin in the treatment of brucellosisbrucellosis.BrucellosisIRCT20201015049030N2Tehran University of Medical Sciences55
Completed
Not Applicable
Effect of anterior chamber paracentesis to control the pressure of the eye after cataract surgeryIRCT20091030002647N2Kerman University of Medical Sciences68
Completed
Phase 3
A comparison of the efficacy of Plavix and Osivix in patients undergoing Coronary artery by passIRCT201112178428N1Research Deputy of Hamadan University of Medical Sciences80
Not yet recruiting
Phase 3
Evaluation of the effect of Medvac IVIg on PIDPrimary immunodeficiency disorder.D84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.D84.9IRCT20101012004920N9Medvac BioPharma Company50
Completed
Not Applicable
se of nitrous oxide for laparoscopic cholecystectomycholelithiasis.Calculus of gallbladder without cholecystitisIRCT138806092389N1Jundi Shapur Medical University64